Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
3(27%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
18%
Ph phase_1
6
55%
Ph phase_2
2
18%
Ph phase_3
1
9%

Phase Distribution

6

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
6(54.5%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(5)
Completed(5)
Other(1)

Detailed Status

Completed5
Not yet recruiting2
Recruiting2
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (54.5%)
Phase 22 (18.2%)
Phase 31 (9.1%)
N/A2 (18.2%)

Trials by Status

not_yet_recruiting218%
completed545%
recruiting218%
unknown19%
active_not_recruiting19%

Recent Activity

3 active trials
Showing 5 of 11
recruitingphase_2

Glucokinase Activator in Monogenic Diabetes

NCT06976658
recruitingphase_1

Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis

NCT06995651
active_not_recruitingphase_3

Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity

NCT05098470
completedphase_1

Drug Interaction Study Between Dorzagliatin and Empagliflozin

NCT03790787
not_yet_recruitingnot_applicable

Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes

NCT06671340
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06976658Phase 2

Glucokinase Activator in Monogenic Diabetes

Recruiting
NCT06995651Phase 1

Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis

Recruiting
NCT05098470Phase 3

Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity

Active Not Recruiting
NCT03790787Phase 1

Drug Interaction Study Between Dorzagliatin and Empagliflozin

Completed
NCT06671340Not Applicable

Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes

Not Yet Recruiting
NCT06222476Not Applicable

Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.

Not Yet Recruiting
NCT03790839Phase 1

Drug Interaction Study Between Dorzagliatin and Sitagliptin

Completed
NCT05468229Phase 1

Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGT

Unknown
NCT04531631Phase 2

Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes

Completed
NCT04080596Phase 1

DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin

Completed
NCT04080609Phase 1

DDI Study Between Dorzagliatin and Rifampicin

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11